Continence After Vaginal Prolapse Surgery

NCT05312047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 609

Last updated 2025-12-31

No results posted yet for this study

Summary

Urinary incontinence after surgical correction of pelvic organ prolapse (POP) could occur. This is a condition that decreases both patients' satisfaction and quality of life. Reports on the prevalence of urinary incontinence after POP surgery are controversial. Concomitant surgery for incontinence could reduce this prevalence, whereas it increases treatment costs and the likelihood of surgical complications. Therefore, it is of paramount importance to know the exact prevalence of urinary incontinence after POP surgery in our population and the potential risk factors associated with this condition.

Conditions

Interventions

PROCEDURE

Pelvic organ prolapse surgery

Vaginal surgery of any compartment for pelvic organ prolapse

Sponsors & Collaborators

  • Consorci Sanitari de Terrassa

    collaborator OTHER
  • Parc Taulí Hospital Universitari

    collaborator OTHER
  • Hospital de Viladecans

    collaborator OTHER
  • Hospital Universitari de Bellvitge

    collaborator OTHER
  • Hospital d'Igualada

    collaborator OTHER
  • Hospital de Mataró

    collaborator OTHER
  • Fundació Hospital de l'Esperit Sant

    collaborator UNKNOWN
  • Germans Trias i Pujol Hospital

    collaborator OTHER
  • Hospital Santa Caterina

    collaborator UNKNOWN
  • Hospital de Granollers

    collaborator OTHER
  • Hospital del Mar

    collaborator OTHER
  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER
  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    collaborator OTHER
  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Marina Catalan, MD · Vall d'Hebron Barcelona Hospital Campus

  • Jordi Sabadell, MD · Vall d'Hebron Barcelona Hospital Campus

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2025-09-19
Completion
2025-09-19

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05312047 on ClinicalTrials.gov